Back

Validation of cardiovascular disease risk prediction models using population-wide electronic health records for England post COVID-19 pandemic: the SCORE2 family-of-models

3 April 2025 (08:00 - 19:00)
Organised by: Logo
Congress Presentation Part of: Estimating cardiovascular risk: does one score fit all? Cardiovascular Risk Assessment EAPC Premium Access ESC Preventive Cardiology 2025 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Miss Carmen Petitjean

Cambridge (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Combining the systematic coronary risk evaluation (SCORE2-SCORE2-OP) with anthropometric measures to refine 10-year cardiovascular prediction in a population-based cohort study
Miss J. Lopes Oliveira (Lausanne, CH)
Abstract Slides
Presentation thumbnail
Assessment of CV risk by SCORE2 with an online calculator estimates CV risk better compared to 2-dimensional risk charts
Doctor S. Hageman (Utrecht, NL)
Abstract Slides
Presentation thumbnail
Risk stratification in chronic coronary syndrome: real-world application of SMART and EUROASPIRE scores for treatment optimization
Assistant Professor M. German-Sallo (Targu Mures, RO)
Abstract Slides
Presentation thumbnail
Validation of the European SCORE2 algorithm in four European and non-European cohort studies with contrasting populations
Doctor K. Maung (Lausanne, CH)
Abstract Slides
Presentation thumbnail
Risky business: exploring statin eligibility across nine cardiovascular risk prediction models
Mr P. Navickas (Vilnius, LT)
Abstract Slides

Access the full session

Session thumbnail
Estimating cardiovascular risk: does one score fit all?

The Event

Event poster

ESC Preventive Cardiology 2025

3 April - 5 April 2025
You may be interested in
thumbnail
Congress Presentation
Making personalised prevention everyone's business
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Congress Presentation
Saving hearts, extending lives: the impact of risk prevention on lifetime estimates in Germany

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources